Author:
Wang Fei,Liu Jianfeng,Robbins Delira,Morris Kerri,Sit Amos,Liu Yong-Yu,Zhao Yunfeng
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Biochemistry, medical,Cell Biology,Clinical Biochemistry,Pharmaceutical Science,Pharmacology
Reference39 articles.
1. Levine JJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88:323–331
2. Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R et al (1994) Datebase of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res 22:3551–3555
3. Garcia-Cao I, Garcia-Cao M, Martin-Caballero J, Criado LM, Klatt P et al (2002) “Super p53” mice exhibit enhanced DNA damage response, are tumor resistant and age normally. EMBO J 21:6225–6235
4. Tyner SD, Venkatachalam S, Choi J, Jones S, Ghebranious N et al (2002) p53 mutant mice that display early ageing-associated phenotypes. Nature 415:45–53
5. Jia HP (2006) Controversial Chinese gene-therapy drug entering unfamiliar territory. Nat Rev Drug Discov 4:269–270
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献